Acceleration of bone-defect repair by using A-W MGC loaded with BMP2 and triple point-mutant HIF1α-expressing BMSCs

Journal of Orthopaedic Surgery and Research

Volumn 10, Issue 1, 2015, Pages

  Gao, Yuzhong ^a,b   Li, Chen ^b   Wang, Hao ^b   Fan, Guangyu ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b JINZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Bone defects; Bone marrow mesenchymal stem cells; Bone morphogenetic protein 2; Hypoxia inducible factor 1

Indexed keywords

APATITE; APATITE-WOLLASTONITE-CONTAINING GLASS CERAMIC; BONE MORPHOGENETIC PROTEIN 2; HYPOXIA INDUCIBLE FACTOR 1ALPHA; SILICIC ACID;

ANIMAL; BONE MARROW TRANSPLANTATION; BONE REGENERATION; CERAMICS; DRUG EFFECTS; FEMALE; GENETICS; INJURIES; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; PHYSIOLOGY; POINT MUTATION; PROCEDURES; RABBIT; RADIUS; THERAPEUTIC USE; TISSUE SCAFFOLD; WESTERN BLOTTING;

ANIMALS; APATITES; BLOTTING, WESTERN; BONE MARROW TRANSPLANTATION; BONE MORPHOGENETIC PROTEIN 2; BONE REGENERATION; CERAMICS; FEMALE; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; POINT MUTATION; RABBITS; RADIUS; SILICIC ACID; TISSUE SCAFFOLDS;

EID: 84930079524     PISSN: None     EISSN: 1749799X     Source Type: Journal    
DOI: 10.1186/s13018-015-0219-3     Document Type: Article

References (27)

1. Hutchins JT, Kull Jr FC, Bynum J, Knick VC, Thurmond LM, Ray P. Improved biodistribution, tumor targeting, and reduced immunogenicity in mice with a gamma 4 variant of Campath-1H. Proc Natl Acad Sci U S A. 1995;92:11980-4.
2. Abdel-Motal UM, Friedline R, Poligone B, Pogue-Caley RR, Frelinger JA, Tisch R. Dendritic cell vaccination induces cross-reactive cytotoxic T lymphocytes specific for wild-type and natural variant human immunodeficiency virus type 1 epitopes in HLA-A*0201/Kb transgenic mice. Clin Immunol. 2001;101:51-8.
3. Wutzl A, Rauner M, Seemann R, Millesi W, Krepler P, Pietschmann P, et al. Bone morphogenetic proteins 2, 5, and 6 in combination stimulate osteoblasts but not osteoclasts in vitro. J Orthop Res. 2010;28:1431-9.
4. Seregin SS, Amalfitano A. Overcoming pre-existing adenovirus immunity by genetic engineering of adenovirus-based vectors. Expert Opin Biol Ther. 2009;9:1521-31.
5. Fiorenzo P, Mongiardi MP, Dimitri D, Cozzolino M, Ferri A, Montano N, et al. HIF1-positive and HIF1-negative glioblastoma cells compete in vitro but cooperate in tumor growth in vivo. Int J Oncol. 2010;36:785-91.
6. Rufaihah AJ, Haider HK, Heng BC, Ye L, Tan RS, Toh WS, et al. Therapeutic angiogenesis by transplantation of human embryonic stem cell-derived CD133+ endothelial progenitor cells for cardiac repair. Regen Med. 2010;5:231-44.
7. Giaccia A, Siim BG, Johnson RS. HIF-1 as a target for drug development. Nat Rev Drug Discov. 2003;2:803-11.
8. Khan TA, Sellke FW, Laham RJ. Gene therapy progress and prospects: therapeutic angiogenesis for limb and myocardial ischemia. Gene Ther. 2003;10:285-91.
9. Semenza GL. Evaluation of HIF-1 inhibitors as anticancer agents. Drug Discov Today. 2007;12:853-9.
10. Wang Y, Wan C, Deng L, Liu X, Cao X, Gilbert SR, et al. The hypoxia-inducible factor alpha pathway couples angiogenesis to osteogenesis during skeletal development. J Clin Invest. 2007;117:1616-26.
11. Wan C, Gilbert SR, Wang Y, Cao X, Shen X, Ramaswamy G, et al. Activation of the hypoxia-inducible factor-1alpha pathway accelerates bone regeneration. Proc Natl Acad Sci U S A. 2008;105:686-91.
12. Bruick RK, McKnight SL. A conserved family of prolyl-4-hydroxylases that modify HIF. Science. 2001;294:1337-40.
13. Ceradini DJ, Yao D, Grogan RH, Callaghan MJ, Edelstein D, Brownlee M, et al. Decreasing intracellular superoxide corrects defective ischemia-induced new vessel formation in diabetic mice. J Biol Chem. 2008;283:10930-8.
14. Evans CE, Humphries J, Mattock K, Waltham M, Wadoodi A, Saha P, et al. Hypoxia and upregulation of hypoxia-inducible factor 1{alpha} stimulate venous thrombus recanalization. Arterioscler Thromb Vasc Biol. 2010;30:2443-51.
15. Kazi AA, Molitoris KH, Koos RD. Estrogen rapidly activates the PI3K/AKT pathway and hypoxia-inducible factor 1 and induces vascular endothelial growth factor A expression in luminal epithelial cells of the rat uterus. Biol Reprod. 2009;81:378-87.
16. Lando D, Peet DJ, Whelan DA, Gorman JJ, Whitelaw ML. Asparagine hydroxylation of the HIF transactivation domain a hypoxic switch. Science. 2002;295:858-61.
17. Li C, Liu D, Zhang Z, Wang G, Xu N. Triple point-mutants of hypoxia-inducible factor-1alpha accelerate in vivo angiogenesis in bone defect regions. Cell Biochem Biophys. 2013;67:557-66.
18. Tran ED, Schmid-Schonbein GW. An in-vivo analysis of capillary stasis and endothelial apoptosis in a model of hypertension. Microcirculation. 2007;14:793-804.
19. Xiao YF, Wu DD, Liu SX, Chen X, Ren LF. Effect of arsenic trioxide on vascular endothelial cell proliferation and expression of vascular endothelial growth factor receptors Flt-1 and KDR in gastric cancer in nude mice. World J Gastroenterol. 2007;13:6498-505.
20. Morrison A, Brady J. Mandibular reconstruction using nonvascularized autogenous bone grafting. Curr Opin Otolaryngol Head Neck Surg. 2010;18:227-31.
21. Kim I, Kim HJ, Kim HM. Array of amorphous calcium phosphate particles improves cellular activity on a hydrophobic surface. J Biomed Mater Res B Appl Biomater. 2010;93:113-21.
22. Hsu WK, Wang JC, Liu NQ, Krenek L, Zuk PA, Hedrick MH, et al. Stem cells from human fat as cellular delivery vehicles in an athymic rat posterolateral spine fusion model. J Bone Joint Surg Am. 2008;90:1043-52.
23. Liu D, Hu L, Zhang Z, Li QY, Wang G. Construction of human BMP2-IRES-HIF1alphamu adenovirus expression vector and its expression in mesenchymal stem cells. Mol Med Rep. 2013;7:659-63.
24. Fang J, Yang Z, Tan S, Tayag C, Nimni ME, Urata M, et al. Injectable gel graft for bone defect repair. Regen Med. 2014;9:41-51.
25. Simon F, Bockhorn M, Praha C, Baba HA, Broelsch CE, Frilling A, et al. Deregulation of HIF1-alpha and hypoxia-regulated pathways in hepatocellular carcinoma and corresponding non-malignant liver tissue-influence of a modulated host stroma on the prognosis of HCC. Langenbeck's Arch Surg / Deutsche Gesellschaft fur Chirurgie. 2010;395:395-405.
26. Teramoto H, Kawai A, Sugihara S, Yoshida A, Inoue H. Resorption of apatite-wollastonite containing glass-ceramic and beta-tricalcium phosphate in vivo. Acta Med Okayama. 2005;59:201-7.
27. Udoh K, Munar ML, Maruta M, Matsuya S, Ishikawa K. Effects of sintering temperature on physical and compositional properties of alpha-tricalcium phosphate foam. Dent Mater J. 2010;29:154-9.